Gordon Fox • May 14, 2025
Decisions in HCM: Where do Risk Estimates Come From?

by Gordon Fox: 4th in a series

A Caucasian right hand holding a pen rests on a clipboard with writing on it. The writer wears a white lab coat.

Risk is estimated from data

Risk estimates come from data on patients. The fact that the numbers are "estimates" does not mean that they are guesses or made up - it means that they are calculated from real data.

Where do the data come from?

Some of the data comes from prospective studies: patients are enrolled in a study, and their health is monitored for some time. Afterward, we can ask what fraction of patients developed the problem being studied (for example, what fraction of obstructed patients needed septal reduction). If the study is large enough and well designed, we can ask further questions, like how that fraction depends on age, sex, or the patients' gradient at the beginning of the study.


Sometimes, information comes from patient registries. For example, everyone receiving an ICD is asked to enter a registry, and every year after that, they are asked whether their ICD has discharged. Then, we can ask the same sorts of questions: what fraction of patients with ICDs had appropriate discharges (or inappropriate ones) in a given time? Does that depend on factors like body weight or whether the patient has an identified mutation that promotes HCM? And so on.


There are other ways to get risk estimates, but these two are the most reliable.

Bottom line

Bottom line: the estimates of risk come from real data. Some problems come from the way the data are obtained. Scientists know how to handle those problems.

Why is “risk” an estimate?

In everyday language, "estimate" often means "guess" or something similar. Scientists don't mean it that way! Almost all numbers in science are estimates – that means we are calculating the numbers from data using well-developed scientific tools. It doesn't mean that somehow the number is made up. 

And why do the estimates change over time?

Risk estimates can change over time for several reasons. First, we learn more about the science over time. That means we can ask better questions with research, which can change our risk estimates. Second, research samples vary. If we conduct three studies, each with 100 patients, we will likely get three somewhat different numbers. That's because the group of patients used for each study differs slightly from the others. As studies accumulate, it is natural that risk estimates also change.


Read Part 3: Decisions in HCM: Understanding Risk


Read Part 5:  Decisions in HCM: My Risk Estimate Was Wrong


HCMA Blog

By Lisa Salberg July 3, 2025
Summer, greetings to all our big-hearted friends As July approaches, our focus is already on the fall and preparing for some major events, including our annual meeting coming up in October. July will also find us on the west coast in Seattle conducting a regional patient education meeting as part of our big-hearted warrior tour. We have been following the generic drug quality issue in the United States very closely and encourage you to watch the series starting with our Hill briefing in April and following with the additional webinars with our partners at Medshadow and the People's Pharmacy, and of course the ProPublica series of articles. See them all here . We are happy to have a new team member on board - we welcome Pam as our coordinator of both our All Hearts Collaborative and Hearts and Minds project. Over the next few months, you're going to be learning more about these two amazing initiatives and how we are working to provide better services for big hearts regardless of where you live, so we are meeting all of our big-hearted friends where they are. Please stay tuned for updates from these projects coming soon. We are also creating new volunteer opportunities and engagements that we hope will make it easier for you to participate in spreading the message of the importance of diagnosis, the importance of community readiness related to CPR and AED use and, of course, helping patients get to their ultimate diagnosis and getting them on the proper treatment pathways. This July I would like to recognize all of the special birthdays in my family, including HCMA Center of Excellence coordinator, Stacey Titus-brown and my daughter Rebecca Salberg. It's a milestone birthday for Becca - it’s hard to believe I have a 30-year-old child. Wishing you all a happy and healthy summer. Go build some memories!
An official seal in black  & red with white letters that say HCMS Recognized Centers of Excellence
By Sabrina Cuddy July 3, 2025
Getting HCM care at a HCMA Recognized Center of Excellence has a positive impact on patient's outcomes. Find out why in the post by Health Educator Sabrina Cuddy
By Erica Friedman June 26, 2025
Investigative journalists Debbie Cenziper, Megan Rose, Brandon Roberts and Irena Hwang from Pro Publica and NPR have concluded a 14-month long investigation into the quality of generic drugs coming into the United States from overseas. Among the many voices that spoke up for American patients was HCMA Founder and CEO, Lisa Salberg who has felt the effects of low-quality drugs personally. Salberg believes that fixing this problem is something we can do, even in this time, when even health care is highly politicized. Read the key takeaways from ProPublica’s 14-month investigation into the FDA’s oversight of foreign drugmakers in Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs .
More Posts